Catabasis Pharma (CATB), Sarepta Therapeutics (SRPT) Enter DMD Research Collaboration
Tweet Send to a Friend
Catabasis Pharmaceuticals, Inc. (Nasdaq: CATB) and Sarepta Therapeutics, Inc. (Nasdaq: SRPT) announced a joint research collaboration to explore a combination ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
